The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

As per The Business Research Company’s Comprehensive Metabolic Panel (CMP) Testing Global Market Report 2023, The global comprehensive metabolic panel (CMP) testing market is expected to grow from $14.37 billion in 2022 to $15.61 billion in 2023 at a compound annual growth rate (CAGR) of 8.7%. The comprehensive metabolic panel (CMP) testing market is expected to reach $21.25 billion in 2027 at a CAGR of 8%.

What was the major driver in the comprehensive metabolic panel (CMP) testing market?
The increasing prevalence of cardiovascular diseases and diabetes is expected to propel the growth of the comprehensive metabolic panel (CMP) testing market going forward. Cardiovascular disorders affect the heart or blood vessels and are linked to atherosclerosis, the build-up of fatty deposits inside the arteries. Diabetes is a condition that develops when blood glucose levels are too high. Comprehensive metabolic panel (CMP) blood tests detect glucose levels. Thus, with the increasing cases of diabetes and cardiovascular diseases, the need for their diagnosis through blood tests such as the CMP blood test will support the market’s growth. For instance, according to British Heart Foundation, in 2020, all heart and circulatory diseases was accounted at 168,319, up from 163,888. Furthermore, in June 2022, according to the International Diabetes Federation, a Belgium-based diabetes federation, the prevalence of diabetes had increased to 10.5% worldwide, with over half (44.7%) of people still undiagnosed. Therefore, the increasing prevalence of cardiovascular diseases and diabetes is driving the growth of the comprehensive metabolic panel (CMP) testing market.

View More On The Comprehensive Metabolic Panel (CMP) Testing Market Report 2023 – https://www.thebusinessresearchcompany.com/report/comprehensive-metabolic-panel-cmp-testing-global-market-report

What was the key trend in the comprehensive metabolic panel (CMP) testing market?
Technological advancements are a key trend gaining popularity in the comprehensive metabolic panel (CMP) testing market. Major companies operating in the comprehensive metabolic panel (CMP) testing market are developing new technologies to sustain their position in the market. For instance, in April 2022, HealthifyMe, an Indian-based wellness and fitness services company, launched HealthifyPro, a flagship fitness plan. The HealthifyPro plan’s metabolic panel is based on a blood test that may measure more than 80 different factors. The main components of HealthifyPro that are included to track users’ health are a biosensor system (BIOS), a smart scale, health coaches, HealthifyMe’s AI assistant, and a metabolic panel. It integrates data on glucose patterns with the users’ food consumption and other exercise behaviors to create a personalized approach for each user.

Which was the largest region in the comprehensive metabolic panel (CMP) testing market?
North America was the largest region in the comprehensive metabolic panel (CMP) testing market in 2022.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in comprehensive metabolic panel (CMP) testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the comprehensive metabolic panel (CMP) testing market prominent players?
Major players in the comprehensive metabolic panel (cmp) testing market are F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Siemens Healthineers AG, Mayo Clinic, Laboratory Corporation of America Holdings, Mercy, Mount Sinai Health System, Quest Diagnostics Incorporated, Sonic Healthcare Limited, Hologic Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Werfen SA, DiaSorin S.p.A., Randox Laboratories Ltd., ARUP Laboratories Inc., Invitae Corporation, Abaxis Inc., Metropolis Healthcare Limited, Clinical Reference Laboratory (CRL), Centogene AG, Spectra Laboratories, Unipath Systems Ltd., Scion Lab Services LLC, Weldon Biotech Pvt Ltd., Corona Pathology,Ulta Lab Tests LLC, Any Lab Test Now, Applied InGENuity Diagnostics LLC, and Walk-In Lab LLC.

Key comprehensive metabolic panel (CMP) testing market segments
The global comprehensive metabolic panel (CMP) testing market is segmented –
1) By Disease: Kidney Disease, Liver Disease, Diabetes, Other Diseases
2) By Test Type: Proteins, Electrolytes, Kidney Tests, Liver Functional Tests, Glucose
3) By End User: Laboratories, Point Of Care (PoC)

Request A Sample Of The Global Comprehensive Metabolic Panel (CMP) Testing Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12362&type=smp

The Comprehensive Metabolic Panel (CMP) Testing Global Market Report 2023  provides a comprehensive overview on the comprehensive metabolic panel (CMP) testing market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Patient Blood Management Global Market Report 2023
Blood Screening Global Market Report 2023
Blood Culture Tests Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model